ID
32629
Description
Study ID: 102248 Clinical Study ID: 102248 Study Title: Multi-Center Study to Assess the Efficacy, Safety and Immunogenicity of 2 or 3 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly With Routine EPI Vaccinations in Healthy Infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00241644 Study Link: https://clinicaltrials.gov/ct2/show/NCT00241644 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Infections, Rotavirus The visits are defined as follows: Visit 1: (Study/Participation) Day 0, Age: 5-10 weeks, Dose 1 Visit 2: (Study/Participation) Month 1, 30-48 days after Visit 1, Dose 2 Visit 3: (Study/Participation) Month 2, 30-48 days after Visit 2, Dose 3 Visit 4: (Study/Participation) Month 3, 30-48 days after Visit 3, Visit 5: (Study/Participation) 1 year of age, 343-391 days of age For amendment 5: Visit 5: (Study/Participation) 21-48 days after Visit 4 Visit 6: (Study/Participation) 1 year of age, 343-391 days of age This form asks if the patient had any episodes of gastroenteritis between visits. It should be checked on visit 2-5. The HIV-Test itemgroup is part of amendment 4.
Link
https://clinicaltrials.gov/ct2/show/NCT00241644
Keywords
Versions (2)
- 11/1/18 11/1/18 -
- 11/9/18 11/9/18 - Sarah Riepenhausen
Copyright Holder
GlaxoSmithKline
Uploaded on
November 9, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Efficacy, Safety and Immunogenicity of Oral HRV Vaccine NCT00241644
Gastroenteritis Episodes, HIV Testing
- StudyEvent: ODM
Description
Gastroenteritis Episodes
Alias
- UMLS CUI-1
- C0017160
Description
HIV Test
Alias
- UMLS CUI-1
- C1321876
Description
HIV testing should be proposed if a child develops symptoms indicative of AIDS (WHO interim stage III or IV) or has to be hospitalized with SAE, and HIV testing has not yet been performed.
Data type
boolean
Alias
- UMLS CUI [1]
- C1321876
Similar models
Gastroenteritis Episodes, HIV Testing
- StudyEvent: ODM